Synapse - Walter de Gruyter & Co

Walter de Gruyter & Co

SHERPA: Unknown

People

Lilja
Bott
Fleisher
Ladanyi
Rusch
Scher
Vickers

Groups

Surgery (3)
Population Sciences Research Program (2)
Urology (2)
Department of Medicine (1)
Department of Pathology and Laboratory Medicine (1)
Epidemiology and Biostatistics (1)
GSK Faculty (1)
Genitourinary Oncology Service (1)
Health Outcomes Research Group (1)
Human Oncology and Pathogenesis Program (1)

Search Within

Results (3)

Export to EndNote / Excel

Suitability of quality control materials for prostate-specific antigen (PSA) measurement: Inter-method variability of common tumor marker control materials

Journal Article

Vucetic, Z.; Dnistrian, A.; Nilsson, O.; Lilja, H. G.; Plebani, M.
Clinical Chemistry and Laboratory Medicine (2013)

Fulltext@MSK | Save

Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: Potential for rapid monitoring of treatment responses

Journal Article

Ulmert, D.; Vickers, A. J.; Scher, H. I.; Becker, C.; Iversen, P.; Frankel, D.; Jensen, J. K.; Olesen, T. K.; Lilja, H.
Clinical Chemistry and Laboratory Medicine (2012)

Fulltext@MSK | Save

Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: Analytical validation of ELISA based assays and characterization at mRNA and protein levels

Journal Article

Rai, A. J.; Flores, R. M.; Mathew, A.; Gonzalez-Espinoza, R.; Bott, M.; Ladanyi, M.; Rusch, V.; Fleisher, M.
Clinical Chemistry and Laboratory Medicine (2010)

Fulltext@MSK | Save

Walter de Gruyter & Co

People

Groups

Results (3)

Journal Article

Journal Article

Journal Article

Walter de Gruyter & Co – authorized name for: